Zai Lab Limited - American Depositary Shares — Quarterly Cash Flow (NASDAQ:ZLAB) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 985.35 M1.19 B1.17 B1.16 B1.16 B1.17 B Total liabilities 317.68 M344.86 M362.58 M372.37 M399 M456.88 M Total equity 667.67 M840.9 M810.75 M791.74 M759.95 M715.5 M Total liabilities & shareholders' equities 985.35 M1.19 B1.17 B1.16 B1.16 B1.17 B Total debt —————— Net debt ——————

Notizie

Zai Lab Q4 2025 slides: Zoci pipeline drives dual-engine strategy

Zai Lab earnings beat by $0.32, revenue topped estimates

Baron Emerging Markets Fund Q4 2025 Portfolio Activity

Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse.

Sanità ai minimi: 3 titoli in ipervenduto pronti al rimbalzo tecnico - Benzinga Italia

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivos Therapeutics (NASDAQ:VVOS)

Il titolo di Zai Lab tocca il minimo di 52 settimane a 16,78 USD

Zai Lab stock hits 52-week low at 16.78 USD

Zai Lab Limited (ZLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:ZLAB) 2026-01-15

UBS avvia copertura su Zai Lab con rating Buy e target di $35

UBS initiates Zai Lab stock with Buy rating, $35 price target